Browser does not support script.
Our Division is involved in research in acute management, acute interventions, prevention of post-stroke cognitive decline and dementia, and translational stroke studies.
The Nottingham Stroke Trials Unit runs a number of large multi-centre phase 3 clinical trials, both in the UK and Internationally. In addition, we also run a number of smaller phase II clinical trial, as well as performing systematic reviews and meta-analysis. (List of clinical stroke trials.)
Types of studies
Translational studies in the Division focus on the elucidation of the mechanisms that may account for the breakdown and recovery of the blood-brain barrier (BBB) with an aim to discover novel therapeutic mediators that can effectively prevent or reverse the formation of brain oedema, the main cause of death within the first week after an ischaemic stroke.
We maintain strong collaborative links with key groups both within the University of Nottingham and outside with colleagues in the UK, Europe and worldwide.
The Division offers a number of research training opportunities to undergraduates and postgraduates in both clinical and laboratory research.
Currently there are two BMedSci students and seven PhD students (doing both clinical and laboratory-based projects). The Division has had five PhD graduates over recent years.
Find out more about our undergraduate and postgraduate research training opportunities.
Our research impact is reflected in the following:
University of NottinghamClinical Sciences BuildingCity Hospital CampusHucknall Road
telephone: +44 (0)115 82 31765
fax: +44 (0)115 82 31767